BPS Program Book 2014
Name
Disclosure Entity
Disclosure Type
Presentation Number
Leite, Maria F.
CNPq, CAPES, FAPEMIG
Other
1554-Pos 1223-Plat
Lembong, Josephine
Firmenich Inc. Aratome LLC
Research funded by industry grant
Lenzi, David
Ownership or Partnership in funding organization 2012-Pos
Li, Tong
Medimmune LLC
Research funded by industry grant
3292-Pos
Liao, Jinfang
Full time employment with AAT Bioquest
Employment (full or part-time) in funding company 1859-Pos
Lilja, Kaisa E. Liu, Gongxin
Biolin Scientific Gilead Sciences
Employment (full or part-time) in funding company 3153-Pos Employment (full or part-time) in funding company 1664-Pos
Liu, Fei
Bill & Melinda Gates Foundation Research funded by industry grant
2108-Pos 3292-Pos
Livesay, Dennis R.
Medimmune LLC
Research funded by industry grant
Lo, Michael
Anasys Instruments Corp. Full time employee of Sophion
Employment (full or part-time) in funding company 1033-Pos Employment (full or part-time) in funding company 2746-Pos
LĂžjkner, Lars D.
Lopaschuk, Gary D.
Metabolic Modulators Research Ltd Stock options or bond holdings in a for-profit corporation or self-directed pension plan
945-Pos
Luerman, Greg
ChanTest
Employment (full or part-time) in funding company 3647-Pos
Ma, Jianjie
TRiM-edicine, Inc
Stock options or bond holdings in a for-profit corporation or self-directed pension plan
503-Pos
Ma, Jianjie Ma, Jianjie
Founder of TRIM-edicine
Other Other
3201-Plat 3687-Pos
Dr. Jianjie Ma has equity interest in TRIM-edicine, Inc. that is developing MG53 as a regenerative medicine agent.
Magdeleine Hung, Magdeleine
Gilead Sciences Inc.
Employment (full or part-time) in funding company 1330-Pos
Malkin, Gene
PathoGenetix
Employment (full or part-time) in funding company 1419-Pos
Manara, Richard
Oxford Nanopore Technologies Co-founder and owner: ActoSense Biotech AB
Research funded by industry grant
2227-Plat 2289-Plat
Mansson, Alf
Other
Markova, Natalia Mayer, Michael Mayer, Michael Meltzer, Robert H. Metzger, Joseph M.
GE Healthcare
Employment (full or part-time) in funding company 1529-Pos
Oxford Nanopore Oxford Nanopore
Research funded by industry grant Research funded by industry grant
1080-Pos 1081-Pos
PathoGenetix
Employment (full or part-time) in funding company 1419-Pos
Phrixus Pharmaceuticals
Stock options or bond holdings in a for-profit corporation or self-directed pension plan
3867-Pos
Miller, William Minner, Daniel E.
GlaxoSmithKline
Employment (full or part-time) in funding company 3267-Plat
Indiana University-Purdue University Indianapolis, Integrated Nanosystem Development Institute, Indianapolis
Other
873-Pos
Mitlo, Trisha
Molecular Devices, LLC Schrodinger Software NSF Career Award Nanion Technologies Nanion Technologies
Employment (full or part-time) in funding company 681-Pos Consulting fees or other remuneration from industry 1265-Plat
Mobley, David L.
Mofrad, Mohammad R.
Other
1208-Plat
Mueller, Max Mumm, Patrick Nguyen, Steven
Employment (full or part-time) in funding company 680-Pos Employment (full or part-time) in funding company 694-Pos Employment (full or part-time) in funding company 1664-Pos Employment (full or part-time) in funding company 1419-Pos Employment (full or part-time) in funding company 2377-Pos
Gilead Sciences PathoGenetix
Nicholson, Andrew
Niedziela-Majka, Anita Gilead Sciences
294
Biophysical Society 58 th Annual Meeting, San Francisco, California
Made with FlippingBook flipbook maker